Caracterização antropométrica e laboratorial dos pacientes testados para SARS-CoV-2 no Hospital do Policial Militar de Goiânia-GO

Rafaella Quirino  Alcântara; Bárbara de Oliveira  Arantes; Clayson Moura  Gomes; Sérgio Henrique Nascente  Costa

doi:10.33448/rsd-v11i14.36218

Autores/as

Rafaella Quirino Alcântara Pontifícia Universidade Católica de Goiás https://orcid.org/0000-0001-7490-0878
Bárbara de Oliveira Arantes Pontifícia Universidade Católica de Goiás https://orcid.org/0000-0001-8685-5111
Clayson Moura Gomes Pontifícia Universidade Católica de Goiás https://orcid.org/0000-0001-8827-8274
Sérgio Henrique Nascente Costa Universidade Federal de Goiás https://orcid.org/0000-0002-4225-6368

DOI:

https://doi.org/10.33448/rsd-v11i14.36218

Palabras clave:

COVID-19; Técnicas de laboratorio clínico; Policía.

Resumen

Objetivo: encontrar cambios entre pruebas de laboratorio de pacientes testeados para COVID-19. Metodología: Se realizó un estudio analítico observacional con personal militar y sus familiares mayores de 18 años a quienes se les realizó la prueba de COVID-19 y fueron seguidos en el Hospital do Policial Militar. Se realizó un análisis comparativo entre datos antropométricos, grupo de edad, sexo y las siguientes pruebas: proteína C reactiva (PCR), dímero D, velocidad de sedimentación globular (VSG), alanina aminotransferasa (ALT), aspartato aminotransferasa (AST) y lactato deshidrogenasa (DHL), ferritina, urea, creatinina, creatina quinasa (CK) y troponina I. Se realizó un análisis descriptivo, con media y desviación estándar, además de la prueba f y la prueba ANOVA con un nivel de significancia (p < 0,05). Resultados: Del total de 4499 pacientes, 2646 (59%) eran hombres y 3094 (69%) sujetos tenían RT-PCR para SARS-CoV-2 no detectado. La media de edad más baja fue el sexo femenino, 28 años (±13,55) y el IMC total más alto, 27,81 (±4,45), ambos en el grupo detectado/no concluyente. Además, el grupo con RT-PCR detectada/no concluyente tenía dímero D, CRP, AST, ALT, DHL, ferritina y creatinina significativamente más altos que el grupo no detectado. Conclusión: Se pudo observar una relación significativa entre obesidad, COVID-19, género masculino y edad avanzada (mayor de 51 años) con aumento en los valores de exámenes de laboratorio (p<0,05).

Citas

Borges do Nascimento, I. J., Pinto, L. R., Fernandes, V. A., Romero, I. M., Oliveira, J. A. de Q., Marcolino, M. S., & Leite, M. F. (2020). Clinical characteristics and outcomes among Brazilian patients with severe acute respiratory syndrome coronavirus 2 infection: An observational retrospective study. Sao Paulo Medical Journal, 138(6), 490–497.

Bulut, C., & Kato, Y. (2020). Epidemiology of covid-19. Turkish Journal of Medical Sciences, 50(SI-1), 563–570.

Cai, Q., Chen, F., Wang, T., Luo, F., Liu, X., Wu, Q., He, Q., Wang, Z., Liu, Y., Liu, L., Chen, J., & Xu, L. (2020). Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care, 43(7), 1392–1398.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., & Yu, T. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan , China : a descriptive study. The Lancet, 395(10223), 507–513.

Civil, S. de E. da C. (2012). LEI No 17.866, DE 19 DE DEZEMBRO DE 2012. 1–3.

Daly, J. L., Simonetti, B., Klein, K., Chen, K. E., Williamson, M. K., Antón-Plágaro, C., Shoemark, D. K., Simón-Gracia, L., Bauer, M., Hollandi, R., Greber, U. F., Horvath, P., Sessions, R. B., Helenius, A., Hiscox, J. A., Teesalu, T., Matthews, D. A., Davidson, A. D., Collins, B. M., … Yamauchi, Y. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science, 370(6518), 861–865.

Dong, L., Tian, J., He, S., Zhu, C., Wang, J., Liu, C., & Yang, J. (2020). Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA, 10(1), 49–61.

Fung, T. S., & Liu, D. X. (2019). Human coronavirus: Host-pathogen interaction. In Annual Review of Microbiology (Vol. 73, Issue 1, pp. 529–557).

Gao, F., Zheng, K. I., Wang, X., Sun, Q., Pan, K., Wang, T., Chen, Y., Targher, G., Byrne, C. D., & George, J. (2020). Obesity Is a Risk Factor for Greater COVID-19 Severity. 43(April), 72–74.

Ge, X. Y., Li, J. L., Yang, X. Lou, Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., Zhang, Y. J., Luo, C. M., Tan, B., Wang, N., Zhu, Y., Crameri, G., Zhang, S. Y., Wang, L. F., Daszak, P., & Shi, Z. L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, 503(7477), 535–538.

Heininger, U. (2020). Severe acute respiratory syndrome coronavirus 2 vaccines: Setting expectations appropriately. Pediatric Infectious Disease Journal, January, 123-14.

Henry, B. M., De Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020). Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. In Clinical Chemistry and Laboratory Medicine (Vol. 58, Issue 7, pp. 1021–1028).

Jaillon, S., Berthenet, K., & Garlanda, C. (2019). Sexual Dimorphism in Innate Immunity. Clinical Reviews in Allergy & Immunology, 56(3), 308–321.

Jakhmola, S., Baral, B., & Jha, H. C. (2021). A comparative analysis of COVID-19 outbreak on age groups and both the sexes of population from India and other countries. Journal of Infection in Developing Countries, 15(3), 333–341.

Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of covid-19. In Viruses, 12,1-17.

Kass, D. A., Duggal, P., & Cingolani, O. (2020). Obesity could shift severe COVID-19 disease to younger ages. The Lancet, 395(10236), 1544–1545.

Li, H., Xiang, X., Ren, H., Xu, L., Zhao, L., Chen, X., Long, H., Wang, Q., & Wu, Q. (2020). Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. Journal of Infection, 80(6), 646–655.

Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. In Journal of Pharmaceutical Analysis (Vol. 10, Issue 2, pp. 102–108). Elsevier Ltd.

Liang, W., Liang, H., Ou, L., & Al, E. (2020). Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. 180(8), 1081–1089.

Lippi, G., & Plebani, M. (2020). Laboratory abnormalities in patients with COVID-2019 infection. 58(7), 1131–1134.

Maria Falci Vieira, L., Emery, E., & Andriolo, A. (n.d.). COVID-19-Diagnóstico Laboratorial para Médicos. 1–19.

Mayi, B. S., Leibowitz, J. A., Woods, A. T., Ammon, K. A., Liu, A. E., & Raja, A. (2021). The role of Neuropilin-1 in COVID-19. PLoS Pathogens, 17(1), 1–8.

Peckham, H., de Gruijter, N. M., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., Rosser, E. C., Webb, K., & Deakin, C. T. (2020). Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications, 11(1), 1–10.

Ritchie, H., Mathieu, E., Rodés-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., Hasell, J., Macdonald, B., Beltekian, D., & Roser, M. (2020). Coronavirus Pandemic (COVID-19). Our World in Data.

Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020). Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases, 20(4), 425–434.

Sinha, N., & Balayla, G. (2020). Sequential battery of COVID-19 testing to maximize negative predictive value before surgeries. In Revista do Colegio Brasileiro de Cirurgioes (Vol. 47, pp. 1–14).

Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020). Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano, 14(4), 3822–3835.

van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., Lloyd-Smith, J. O., de Wit, E., & Munster, V. J. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564–1567.

Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging, 12(7), 6049–6057.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA - Journal of the American Medical Association, 323(11), 1061–1069.

Woloshin, S., Patel, N., & Kesselheim, A. S. (2020). False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications. New England Journal of Medicine, 383(6), e38.

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Hu, Y., Song, Z.-G., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E., & Zhang, Y.-Z. (2020). Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. 1-32.

Yang, S., Stanzione, N., Uslan, D. Z., Garner, O. B., & De St Maurice, A. (2021). Clinical and Epidemiologic Evaluation of Inconclusive COVID-19 PCR Results Using a Quantitative Algorithm. American Journal of Clinical Pathology, 155(3), 376–380.

Yuan, X., Huang, W., Ye, B., Chen, C., Huang, R., Wu, F., Wei, Q., Zhang, W., & Hu, J. (2020). Changes of hematological and immunological parameters in COVID-19 patients. International Journal of Hematology, 112(4):553-559.

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., Qian, S., Hong, C., Wang, F., Liu, Y., Wang, Z., He, Q., Li, Z., He, B., Zhang, T., … Zhang, Z. (2020). Antibody Responses to SARS-CoV-2 in Patients with Novel Coronavirus Disease 2019. Clinical Infectious Diseases, 71(16), 2027–2034.

Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., Ye, C., Zhang, P., Xing, Y., Guo, H., & Tang, W. (2020). Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. Journal of Infection, 81(2), e16–e25.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062.

Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of Medicine, 14(2), 185–192.

Caracterización antropométrica y de laboratorio de los pacientes testados para SARS-CoV-2 en el Hospital de la Policía Militar de Goiânia-GO

Autores/as

DOI:

Palabras clave:

Resumen

Citas

Descargas

Publicado

Cómo citar

Número

Sección

Licencia

JOURNAL METRICS

Idioma

Enviar un artículo